Celltrion Will Trial COVID-19 Antiviral From July

Company Identifies 14 Antibodies Most Potent For Neutralizing Coronavirus

 
• By Akriti Seth

Celltrion has made progress in finding an effective treatment for COVID-19 by identifying 14 antibodies able to neutralize coronavirus. The company aims to eventually roll out mass production of a therapeutic antibody treatment after starting human trials this July.

Syringe_Covid19_Cell
Celltrion’s COVID-19 antiviral treatment enters the next phase of development • Source: Shutterstock

More from Products

More from Generics Bulletin